Aldesleukin Recruiting Phase 2 Trials for Myeloid Leukemias / Leukemia Acute Myeloid Leukemia (AML) / Leukemias Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02763475NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents